The fact that everything looks different doesn't mean that all has changed...
Biblio
Export 98 results:
Author Title [ Type
] Year Filters: First Letter Of Last Name is J [Clear All Filters]
. The genetic causes of primary lymphedema. In: . Erkrankungen des Lymphgefäßsystems. 6th ed. Cologne: Viavital Verlag; 2015. pp. 210-229. 
Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB)
Mattonet et al. 2015: The genetic causes of primary lymphedema. [English] (3.8 MB) Mattonet et al. 2015: The genetic causes of primary lymphedema. [German] (676.52 KB). The TIE Receptor Family. In: . Receptor Tyrosine Kinases: Family and Subfamilies [Internet]. Springer International Publishing; 2015. pp. 743-775. https://link.springer.com/content/pdf/10.1007%2F978-3-319-11888-8_16.pdf
. VEGF Receptors. In Sigma-RBI Handbook of Receptor Classification and Signal Transduction [Internet]. 5.th ed. Sigma; 2006. http://www.sigmaaldrich.com/technical-documents/articles/biology/rbi-handbook.html Sigma-RBI Handbook of Receptor Classification and Signal Transduction: VEGF Receptors (263.92 KB)
Sigma-RBI Handbook of Receptor Classification and Signal Transduction: VEGF Receptors (263.92 KB). Inhibiton of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171. In 98th Annual Meeting of the American-Association-for-Cancer-Research [Internet]. Los Angeles, CA: American Association for Cancer Research; 2007. http://dx.doi.org/10.1158/0008-5472.CAN-07-5809 Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB)
Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB). Inhibiton of VEGF-C-induced VEGFR-3 activity and lymphatic endothelial cell function by the tyrosine kinase inhibitor AZD2171. In 98th Annual Meeting of the American-Association-for-Cancer-Research [Internet]. Los Angeles, CA: American Association for Cancer Research; 2007. http://dx.doi.org/10.1158/0008-5472.CAN-07-5809 Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB)
Heckman et al. - 2007 - Inhibiton of VEGF-C-induced VEGFR-3 activity and l.pdf (236.37 KB). Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. Jussila et al., 2001 (279.47 KB)
Jussila et al., 2001 (279.47 KB). Signalling via VEGFR-3 is sufficient for lymphangiogenesis in transgenic mice. In Molecular Targets and Cancer Therapeutics: Discovery, Biology, and Clinical Applications. Miami Beach, Florida; 2001. Jussila et al., 2001 (279.47 KB)
Jussila et al., 2001 (279.47 KB). What you should know about VEGF-C when working with lymphatics [German]. In Lymphologie 2017 [Internet]. Bad Soden (Frankfurt), Germany; 2017. https://jeltsch.org/Abstrakt-BadSoden2017 Extended Abstract (published in Vasomed, 2018) (226.5 KB)
Extended Abstract (published in Vasomed, 2018) (226.5 KB). From molecular biology to a causal treatment of lymphatic system disorders [Internet]. 38. Jahreskongress der Deutschen Gesellschaft für Lymphologie e. V. Halle (Saale), Germany: Deutsche Gesellschaft für Lymphologie; 2014. https://jeltsch.org/abstract-Halle2014
. From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders [Internet]. 42nd Congress of the European Society of Lymphology. Mulhouse, France; 2016. http://www.eurolymphology.org/JOURNAL/VOL28-N74-2016/#p=14 Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB)
Jeltsch 2016: From Molecular Genetics and Biology to Effective Treatments of Lymphatic Disorders (683.85 KB). Lymphangiogenesis in Health and Disease [Internet]. 41st European Societry of Lymphology (ESL) Congress. Lausanne, Switzerland: European Group of Lymphology; 2015. http://www.eurolymphology.org/JOURNAL/VOL26-N72-2015/#p=10 Abstract of the Presentation (Michael Jeltsch) (75.34 KB)
Abstract of the Presentation (Michael Jeltsch) (75.34 KB). Activated forms of VEGF-C and VEGF-D provide improved vascular function in skeletal muscle. Circ Res [Internet]. 2009;104(11):1302 - 12. http://view.ncbi.nlm.nih.gov/pubmed/19443835 Andrey Anisimov et al., Circulation Research 2009 (8.03 MB) Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB)
Andrey Anisimov et al., Circulation Research 2009 (8.03 MB) Andrey Anisimov et al., Circulation Research 2009, supplement (5.9 MB). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res [Internet]. 2001;88(6):623 - 9. http://view.ncbi.nlm.nih.gov/pubmed/11282897 Bernd Enholm et al., Circulation Research 2001 (2.93 MB)
Bernd Enholm et al., Circulation Research 2001 (2.93 MB). Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin. Circ Res [Internet]. 2001;88(6):623 - 9. http://view.ncbi.nlm.nih.gov/pubmed/11282897 Bernd Enholm et al., Circulation Research 2001 (2.93 MB)
Bernd Enholm et al., Circulation Research 2001 (2.93 MB). Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J [Internet]. 2002;16(9):1041 - 9. http://view.ncbi.nlm.nih.gov/pubmed/12087065 Anne Saaristo et al., FASEB Journal 2002 (966.08 KB)
Anne Saaristo et al., FASEB Journal 2002 (966.08 KB). The basis for the distinct biological activities of vascular endothelial growth factor receptor-1 ligands. Sci Signal. 2013;6(282):ra52. Anisimov 2013 Science Signaling (1.92 MB) Anisimov 2013 Science Signaling Supplement (2.09 MB)
Anisimov 2013 Science Signaling (1.92 MB) Anisimov 2013 Science Signaling Supplement (2.09 MB). Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Frontiers in Biotechnology and Bioengineering [Internet]. 2018;6. https://www.frontiersin.org/articles/10.3389/fbioe.2018.00007/full Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB)
Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB). Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels. Frontiers in Biotechnology and Bioengineering [Internet]. 2018;6. https://www.frontiersin.org/articles/10.3389/fbioe.2018.00007/full Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB)
Rauniyar et al. - Biology of Vascular Endothelial Growth Factor C in the Morphogenesis of Lymphatic Vessels (4.42 MB). CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation [Internet]. 2014;129(19). http://circ.ahajournals.org/content/early/2014/02/19/CIRCULATIONAHA.113.002779.abstract Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB)
Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB). CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation. Circulation [Internet]. 2014;129(19). http://circ.ahajournals.org/content/early/2014/02/19/CIRCULATIONAHA.113.002779.abstract Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB)
Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (6.6 MB) Postprint of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated VEGF-C activation (Suppl.) (2.38 MB) Published version of Jeltsch et al. 2014 (Circulation): CCBE1 enhances lymphangiogenesis via ADAMTS3-mediated... (incl. suppl.) (23.21 MB). Claudin-like protein 24 interacts with the VEGFR-2 and VEGFR-3 pathways and regulates lymphatic vessel development. Genes Dev [Internet]. 2010;24(9):875 - 80. http://view.ncbi.nlm.nih.gov/pubmed/20439428 Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB)
Pipsa Saharinen et al., Genes & Development 2010 (1.2 MB) Pipsa Saharinen et al., Genes & Development 2010, supplement (9.15 MB). Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181(5):1607-20.
. Critical role of VEGF-C/VEGFR-3 signaling in innate and adaptive immune responses in experimental obliterative bronchiolitis. Am J Pathol. 2012;181(5):1607-20.
. Current biology of VEGF-B and VEGF-C. Curr Opin Biotechnol [Internet]. 1999;10(6):528 - 35. http://view.ncbi.nlm.nih.gov/pubmed/10600689 Birgitta Olofsson et al., Current Opinion in Biotechnology 1999 (577.33 KB)
Birgitta Olofsson et al., Current Opinion in Biotechnology 1999 (577.33 KB). Die lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseases of the lymphatic system. [bilingual: English, German]. Lymphologie in Forschung und Praxis [Internet]. 2013;17(2):96 - 104. http://jeltsch.org/sites/jeltsch.org/files/JeltschMichael_Lymphforsch2013_96.pdf Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB)
Krebs & Jeltsch (2013): The lymphangiogenic growth factors VEGF-C and VEGF-D. Part 2: The role of VEGF-C and VEGF-D in diseas... (3.88 MB) Krebs & Jeltsch (2013): Die lymphangiogenen Wachstumsfaktoren VEGF-C und VEGF-D. Teil 2. Die Rolle von VEGF-C und VEGF-D bei ... (2.6 MB)